ZGC Group was established in 2010. With a consistent mission of serving innovation-driven development, it has been committed to building an open and shared ecosystem pooling innovation factors. To promote the transformation and industrialization of sci-tech achievements, it deploys innovative resources across the world by means of building high-tech parks, making investments, providing funding and professional services and etc. It now has become an integral part of Zhongguancun innovation and entrepreneurship ecosystem.

ZGC Group

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Kaitai Capital

Lapam Capital is a healthcare-focused venture capital firm.

Lapam Capital

Phoenix Fund is a private equity investment fund company.

Phoenix Fund

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

TF Capital

Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund（SHENZHEN）LLP with a size of 6 Billion Yuan. Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhen venture capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%).

Shenzhen Guozhong Venture Capital Management

''Yan Chuang Capital'', the full name of ''Yanyuan Innovation Capital Group'', was founded in June 2010, formerly known as ''Yanyuan Capital Group''. A high-tech enterprise investment and capital operation platform co-sponsored by Peking University alumni who have transformed achievements. Yanchuang Capital always takes value investment as the core, adhering to the corporate philosophy of ''Integrity and character, customer-centered, and ultimate work'', based on the excavation of China's outstanding achievements in the historical trend of economic growth, technological catch-up, and corporate growth. Enterprises and entrepreneurs; take capital as the main channel and provide empowerment services, and create greater value for investors through common growth and win-win development with outstanding enterprises and entrepreneurs.

Yanchuang Capital

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Qiming Venture Partners

Established in 1995 as the first joint venture investment bank in China, China International Capital Corporation Limited (CICC) is a leader in providing comprehensive financial services including investment banking, capital markets, institutional and individual securities sales and trading, fixed income, asset management, private equity, individual wealth management and research.

CICC

Yunfeng Capital was established in January 2010. It is the only private equity firm in China set up by successful entrepreneurs, pioneers and industry leaders. Its goal is not merely to be a financial investor, but also to share the entrepreneurial experience with companies, helping them refine their development, organizational management and brand building strategies.  Yunfeng Capital places a special emphasis on young entrepreneurs, grooming future leaders to lead world-class enterprises. Yunfeng is the result of combining the Chinese first names of Mr. Jack MA (Yun), Chairman of Alibaba, and Mr. David YU (Feng), Founder of Target Media.  In addition, there are more than 10 other co-founders, including Mr. Yu Zhu SHI, Chairman of Giant interactive group, Mr. Yong Hao LIU, Chairman of New Hope Group, Mr. Guo Jun SHEN, Chairman of Intime Investment, Mr. Yu Suo WANG, Chairman of ENN Group, Mr. Jason JIANG, Chairman of Focusmedia, Mr. Hang XU, Chairman of Shenzhen Mindray Medical, Mr. Yi Hong CHEN, Chairman of China Dongxiang(Group), Mr. Xin ZHOU, Chairman of E-House (China), Mr. Jian Guo WANG, Founder of Fivestar, Mr. Shao Xiong ZHOU, Chairman of Septwolves, Mr. Xu Ning WANG, Chairman of Joyong Holdings, Mr. You Cai ZHANG, President of Unifront Holdings.  Yunfeng Capital is headquartered in Shanghai. Branch offices are located in Hong Kong, Beijing, Hangzhou, and other mainland cities.

YF Capital

Gopher Asset Management is an asset management firm that focuses on asset allocation and pursues absolute returns. The firm also focuses on Private Equity Investment, Real Estate Fund Investment, Secondary Market Investment, Family Office, and Discretionary Account Investment and Institutional Services. They devoted to protecting their investors against financial risk and growing the value of their assets. Gopher Asset Management was founded in 2010 and is based in Shanghai, China.

Gopher Asset Management

V-Capital is supporting Chinese enterprises with transformation and upgrading by M&A or other strategic cooperative methods,  sculpturing the art of investment globally They invest globally based on the demands of our clients. We also deliver strategic advice and solutions to Chinese public corporations, private enterprises, and other institutions.

V-Capital

In Capital is a value-oriented, research-driven, independent-thinking venture capital firm.

In Capital

TriWise Capital is an investment firm that focuses on venture capital and M&A business.

TriWise Capital

Xiamen C&D Co., Ltd is a state-owned enterprise in Xiamen City. Founded in December 1980, after more than 30 years of innovation and transformation, the company has developed into a large industrial investment enterprise group with a registered capital of 5 billion Yuan, an annual operating income of over 220 billion Yuan and total assets of more than 210 billion Yuan, ranking 362th among the Global Fortune 500 companies in 2018, 112th among the top 500 Chinese companies and 49th among the top 500 Chinese service companies. From now on, their Corporation will expand the investment to existing core businesses, properly increase the investment to current emerging industries, actively carry out the capital operation on other invested enterprises, and try to invest in some new fields. Moreover, they will combine traditional industry project with high-tech projects, industrial investment with strategic investment and risk investment, and independent investment operation with joint-venture cooperation, so as to urge the formation and upgrade of the core competitiveness in key fields, realize the big increase of investment gain and the appreciation of core business brands, and promote the stable development of their Corporation.

Xiamen C&D Corporation

SAIC Capital Company is a venture capital firm specializing in direct and fund of funds investments. The company serves as the domestic professional investment management platform and third-party asset management platform of Shanghai Automotive Group Co., Ltd. (''SAIC Group'', 600104.SH for short). Through the development of private equity and private equity securities and strategic investments, it creates value for SAIC and various investors. It was incorporated on May 6, 2011 and is based in Shanghai, China.

SAIC Capital

IFSC is an innovative venture investment management firm.

IFSC

Haoshuo Zhier Fund

Homsun Capital

Tigermed is a contract research organization providing whole-process clinical trial services for the research and development of pharmaceutical products.

Tigermed

Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector.  Yingke Capital prefers to invest in companies with high technology R&D and production capacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.

Yingke Capital

BioTrack Capital is a China-based investment firm.

BioTrack Capital

Huayin Finance & Investment is a venture capital firm.

Huayin Finance & Investment

Asieris Pharmaceuticals

Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.

Asieris Pharmaceuticals

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless